# FDA 483 - Aaron E. Miller, M.D. - April 21, 2022

Source: https://www.keypedia.com/records/483/aaron-e-miller-md/c59072b4-3635-4bff-a887-c67406463471

> FDA 483 for Aaron E. Miller, M.D. on April 21, 2022. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Aaron E. Miller, M.D.
- Inspection Date: 2022-04-21
- Product Type: drugs
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: An FDA inspection of Aaron E. Miller, M.D. in New York, NY, a clinical investigator, revealed significant deficiencies in the conduct of a clinical trial. Observations included failures to promptly report serious adverse events to the sponsor, multiple instances of not adhering to the investigational protocol, and inadequate record-keeping for investigational drug disposition. These issues indicate a lack of proper oversight and adherence to clinical trial regulations.

## Related Officers

- [investigator](https://www.keypedia.com/people/benton-m-ketron/34d763d8-4374-4c8b-8dd6-dce1a83dcd01)

Company: https://www.keypedia.com/companies/aaron-e-miller-md/e97f1212-4707-4ce2-8951-1baacf9f21a8

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961